Diagnostic biomarkers in ovarian cancer: advances beyond CA125 and HE4
Ovarian cancer (OC) is the most lethal gynaecologic malignancy, attributed to its insidious growth, non-specific symptoms and late presentation. Unfortunately, current screening modalities are inadequate at detecting OC and many lack the appropriate specificity and sensitivity that is desired from a...
| الحاوية / القاعدة: | Therapeutic Advances in Medical Oncology |
|---|---|
| المؤلفون الرئيسيون: | , , , , , , , , , , , , |
| التنسيق: | مقال |
| اللغة: | الإنجليزية |
| منشور في: |
SAGE Publishing
2024-02-01
|
| الوصول للمادة أونلاين: | https://doi.org/10.1177/17588359241233225 |
